MBA
AMGN icon

McQueen Ball & Associates’s Amgen AMGN Stock Holding History

McQueen Ball & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.15M Buy
11,055
+1
+0% +$195 1.38% 25
2018
Q3 		$2.29M Sell
11,054
-20
-0.2% -$3.94K 1.3% 26
2018
Q2 		$2.04M Sell
11,074
-275
-2% -$48.6K 1.24% 28
2018
Q1 		$1.94M Buy
11,349
+49
+0.4% +$8.99K 1.18% 32
2017
Q4 		$1.97M Sell
11,300
-48
-0.4% -$8.49K 1.18% 32
2017
Q3 		$2.12M Buy
11,348
+98
+0.9% +$17.4K 1.36% 25
2017
Q2 		$1.94M Buy
11,250
+183
+2% +$29.8K 1.27% 28
2017
Q1 		$1.82K Buy
11,067
+583
+6% +$96.9K 0.99% 32
2016
Q4 		$1.53M Sell
10,484
-264
-2% -$39.7K 1.02% 42
2016
Q3 		$1.79M Sell
10,748
-89
-0.8% -$15.1K 1.22% 27
2016
Q2 		$1.65M Buy
10,837
+195
+2% +$30.3K 1.17% 33
2016
Q1 		$1.6M Buy
10,642
+182
+2% +$27K 1.17% 32
2015
Q4 		$1.7M Buy
+10,460
New +$1.64M 1.54% 20

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McQueen Ball & Associates's AMGN Position: Q4 2018 in Review

McQueen Ball & Associates increased its Amgen (AMGN) stake by 0.01% in Q4 2018, buying an estimated $195 and bringing the position to 11,055 shares worth $2.15M. The position accounts for 1.38% of the portfolio, ranked #25.

McQueen Ball & Associates first reported a position in AMGN in Q4 2015 and has held it in 13 quarters since. The position peaked at $2.29M in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • McQueen Ball & Associates held 11,055 shares of Amgen worth $2.15M as of Q4 2018.
  • McQueen Ball & Associates bought 1 Amgen share in Q4 2018, an estimated $195.
  • Amgen made up 1.38% of McQueen Ball & Associates's portfolio in Q4 2018, its #25 holding.
  • McQueen Ball & Associates first reported a position in Amgen in Q4 2015 and has held it in 13 quarters since.
  • McQueen Ball & Associates's Amgen position peaked at $2.29M in Q3 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on McQueen Ball & Associates's 13F filing for Q4 2018, filed 3 Jan 2019.